ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVBP ArriVent BioPharma Inc

0.00
0.00 (0.00%)

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2023Mar 2024
USD (US$)USD (US$)
Total Assets 163.1M327.84M
Total Current Assets 159.97M327.48M
Cash and Equivalents 150.39M317.39M
Total Non-Current Assets 3.13M358k
Total Liabilities 11.8M10.12M
Total Current Liabilities 11.62M9.98M
Total Non-Current Liabilities 177k138k
Common Equity 03k
Retained Earnings -157.85M-175.26M
Year End 31 December 2023 20222023
USD (US$)USD (US$)
Total Assets 182.83M163.1M
Total Current Assets 182.62M159.97M
Cash and Equivalents 163.37M150.39M
Total Non-Current Assets -85.11M-153.19M
Total Liabilities 8.37M11.8M
Total Current Liabilities 8.36M11.62M
Total Non-Current Liabilities 11k177k
Total Equity -85.11M-153.19M
Common Equity 4k0
Retained Earnings -88.51M-157.85M

Your Recent History

Delayed Upgrade Clock